| abstract |
A compound represented by the general formula (I), which has a strong Axl inhibitory activity by introducing a characteristic bicyclic structure in which a saturated carbocycle is fused to a pyridone ring, and can be a therapeutic agent for Axl-related diseases such as , cancers such as acute myeloid leukemia, melanoma, breast cancer, pancreatic cancer, and glioma, kidney disease, immune system disease, and circulatory system disease. |